Frank Kolbinger

3.0k total citations
50 papers, 2.1k citations indexed

About

Frank Kolbinger is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Frank Kolbinger has authored 50 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Immunology, 18 papers in Molecular Biology and 15 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Frank Kolbinger's work include Psoriasis: Treatment and Pathogenesis (20 papers), Monoclonal and Polyclonal Antibodies Research (15 papers) and Glycosylation and Glycoproteins Research (9 papers). Frank Kolbinger is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (20 papers), Monoclonal and Polyclonal Antibodies Research (15 papers) and Glycosylation and Glycoproteins Research (9 papers). Frank Kolbinger collaborates with scholars based in Switzerland, United States and Germany. Frank Kolbinger's co-authors include Andreas Katopodis, Jürgen Fritz, Dario Anselmetti, Dhavalkumar D. Patel, Christian Antoni, David M. Lee, Sebastian Spindeldreher, Markus Streiff, Anette Karle and Philip Jarvis and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Frank Kolbinger

49 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frank Kolbinger Switzerland	25	1.1k	648	385	301	262	50	2.1k
Wolfgang Bauer Austria	27	796 0.8×	555 0.9×	359 0.9×	459 1.5×	144 0.5×	104	2.8k
John A. Gebe United States	25	945 0.9×	642 1.0×	246 0.6×	26 0.1×	228 0.9×	52	2.0k
Richard Huijbens Netherlands	18	1.1k 1.0×	630 1.0×	188 0.5×	35 0.1×	97 0.4×	21	2.0k
Lars Mattsson Sweden	20	194 0.2×	807 1.2×	507 1.3×	297 1.0×	141 0.5×	33	2.4k
Werner Meier United States	23	1.4k 1.3×	802 1.2×	606 1.6×	75 0.2×	120 0.5×	40	2.7k
Rufus W. Burlingame United States	26	1.1k 1.0×	1.1k 1.6×	597 1.6×	53 0.2×	1.1k 4.3×	58	2.8k
Charles F. Reich United States	28	1.4k 1.4×	1.2k 1.8×	184 0.5×	39 0.1×	322 1.2×	55	2.8k
Stephen C.-T. Lam United States	29	575 0.5×	2.3k 3.6×	171 0.4×	89 0.3×	118 0.5×	37	4.1k
Elisabetta Padovan Switzerland	26	3.0k 2.8×	664 1.0×	464 1.2×	243 0.8×	223 0.9×	48	4.0k
Alistair J. Henry United Kingdom	26	778 0.7×	903 1.4×	741 1.9×	18 0.1×	155 0.6×	51	2.0k

Countries citing papers authored by Frank Kolbinger

Since Specialization

Citations

This map shows the geographic impact of Frank Kolbinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Kolbinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Kolbinger more than expected).

Fields of papers citing papers by Frank Kolbinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Kolbinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Kolbinger. The network helps show where Frank Kolbinger may publish in the future.

Co-authorship network of co-authors of Frank Kolbinger

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Kolbinger. A scholar is included among the top collaborators of Frank Kolbinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Kolbinger. Frank Kolbinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Millar, Neal L., Iain B. McInnes, Frank Kolbinger, et al.. (2025). Targeting the IL-17A pathway for therapy in early-stage tendinopathy. RMD Open. 11(1). e004729–e004729. 2 indexed citations

Barske, Carmen, Sebastian Bergling, Judith Knehr, et al.. (2024). IL-26 Potentiates Type 2 Skin Inflammation in the Presence of IL-1β. Journal of Investigative Dermatology. 144(7). 1544–1556.e9. 3 indexed citations

Lebwohl, Mark, Lars Iversen, Liv Eidsmo, et al.. (2023). Investigation of plaque psoriasis relapse after secukinumab withdrawal in patients from two phase III studies. Clinical and Experimental Dermatology. 49(8). 793–800. 10 indexed citations

Krueger, James G., Richard G. Langley, Simon Nigen, et al.. (2023). Secukinumab versus guselkumab in the complete resolution of ustekinumab‐resistant psoriatic plaques: The ARROW study. Experimental Dermatology. 32(10). 1834–1847. 3 indexed citations

Goepfert, A., Carmen Barske, Sylvie Lehmann, et al.. (2022). IL-17-induced dimerization of IL-17RA drives the formation of the IL-17 signalosome to potentiate signaling. Cell Reports. 41(3). 111489–111489. 18 indexed citations

Kolbinger, Frank, Franco Di Padova, Atul Deodhar, et al.. (2021). Secukinumab for the treatment of psoriasis, psoriatic arthritis, and axial spondyloarthritis: Physical and pharmacological properties underlie the observed clinical efficacy and safety. Pharmacology & Therapeutics. 229. 107925–107925. 29 indexed citations

Spindeldreher, Sebastian, et al.. (2018). Secukinumab Demonstrates Significantly Lower Immunogenicity Potential Compared to Ixekizumab. Dermatology and Therapy. 8(1). 57–68. 33 indexed citations

Kolbinger, Frank, Christian Loesche, Marie‐Anne Valentin, et al.. (2016). β-Defensin 2 is a responsive biomarker of IL-17A–driven skin pathology in patients with psoriasis. Journal of Allergy and Clinical Immunology. 139(3). 923–932.e8. 180 indexed citations

Kolbinger, Frank, Andrew Blauvelt, April W. Armstrong, et al.. (2016). Secukinumab, a novel anti-IL-17A antibody, exhibits low immunogenicity in clinical trials and human in vitro assays. Journal of Dermatological Science. 84(1). e122–e123. 1 indexed citations

10.

Patel, Dhavalkumar D., David M. Lee, Frank Kolbinger, & Christian Antoni. (2012). Effect of IL-17A blockade with secukinumab in autoimmune diseases. Annals of the Rheumatic Diseases. 72. iii116–iii123. 248 indexed citations

11.

Chu, Peter C., H. Zhao, Erlina S. Pali, et al.. (2003). Systematic identification of regulatory proteins critical for T-cell activation. Journal of Biology. 2(3). 21–21. 57 indexed citations

12.

Bonfoco, Emanuela, Erguang Li, Frank Kolbinger, & Neil R. Cooper. (2001). Characterization of a Novel Proapoptotic Caspase-2- and Caspase-9-binding Protein. Journal of Biological Chemistry. 276(31). 29242–29250. 29 indexed citations

13.

Baisch, Gabi, Reinhold Öhrlein, Frank Kolbinger, & Markus Streiff. (1998). On the preparative use of recombinant pig α(1–3)galactosyl-transferase. Bioorganic & Medicinal Chemistry Letters. 8(12). 1575–1578. 9 indexed citations

14.

Baisch, Gabi, Reinhold Öhrlein, Markus Streiff, & Frank Kolbinger. (1998). On the preparative use of recombinant β(1–3)galactosyl-transferase. Bioorganic & Medicinal Chemistry Letters. 8(7). 751–754. 21 indexed citations

15.

Baisch, Gabi, Reinhold Öhrlein, Markus Streiff, & Frank Kolbinger. (1998). Enzymatic synthesis of sialyl-Lewisa-libraries with two non-natural monosaccharide units. Bioorganic & Medicinal Chemistry Letters. 8(7). 755–758. 16 indexed citations

16.

Kolbinger, Frank, Markus Streiff, & Andreas Katopodis. (1998). Cloning of a Human UDP-galactose:2-Acetamido-2-deoxy-d-glucose 3β-Galactosyltransferase Catalyzing the Formation of Type 1 Chains. Journal of Biological Chemistry. 273(1). 433–440. 50 indexed citations

17.

Welschof, Martin, Peter Terness, Frank Kolbinger, et al.. (1995). Amino acid sequence based PCR primers for amplification of rearranged human heavy and light chain immunoglobulin variable region genes. Journal of Immunological Methods. 179(2). 203–214. 69 indexed citations

18.

Kolbinger, Frank, José W. Saldanha, Norman Hardman, & Mary M. Bendig. (1993). Humanization of a mouse anti-human IgE antibody: a potential therapeutic for IgE-mediated allergies. Protein Engineering Design and Selection. 6(8). 971–980. 48 indexed citations

19.

Kolbinger, Frank, et al.. (1989). Expression of an NCA cDNA in NIH3T3 cells yields a 110K glycoprotein, which is anchored into the membrane via glycosyl-phosphatidylinositol. Biochemical and Biophysical Research Communications. 161(3). 1126–1134. 28 indexed citations

20.

Grunert, Fritz, Frank Kolbinger, Klaus Schwarz, Hartwig Schwaibold, & S. von Kleist. (1988). Protein analysis of NCA-50 shows identity to NCA cDNA deduced sequences and indicates posttranslational modifications. Biochemical and Biophysical Research Communications. 153(3). 1105–1115. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact